Qiagen is considering selling a minority stake in its bioinformatics unit, that could value that division at over $1B, Bloomberg’s Dinesh Nair, Michelle Davis and Tim Loh report, citing people familiar with the matter. The company has hired a financial adviser to mull its options as it evaluates bringing on an investor for the business, which is expected to draw interest from private equity firms. Reference Link
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on QGEN: